Weekly chemotherapy as first line treatment in frail head and neck cancer patients in the immunotherapy era

OBJECTIVE: First-line therapy for metastatic squamous cell carcinoma of the head and neck (R/M HNSCC) has been revolutionized by the introduction of anti-checkpoint monoclonal antibodies, which have shown a significant improvement in overall survival (OS) gaining approval in a first line setting. Ef...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Transl Med
Main Authors: Botticelli, Andrea, Pomati, Giulia, Cirillo, Alessio, Mammone, Giulia, Ciurluini, Fabio, Cerbelli, Bruna, Sciattella, Paolo, Ralli, Massimo, Romeo, Umberto, De Felice, Francesca, Catalano, Carlo, Vullo, Francesco, Della Monaca, Marco, Amirhassankhani, Sasan, Tomao, Silverio, Valentini, Valentino, De Vincentiis, Marco, Tombolini, Vincenzo, Della Rocca, Carlo, Polimeni, Antonella, di Gioia, Cira, Corsi, Alessandro, D’Amati, Giulia, Mezi, Silvia, Marchetti, Paolo
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2021
Assuntos:
Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8274020/
https://ncbi.nlm.nih.gov/pubmed/34253248
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12967-021-02975-3
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados